Revelation Biosciences In... (REVB)
undefined
undefined%
At close: undefined
0.37
3.06%
After-hours Dec 13, 2024, 07:21 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue - - - - -
Cost of Revenue 25.05K 40.01K 69.17K - -
Gross Profit -25.05K -40.01K -69.17K - -
Operating Income -8.66M -10.86M -11.95M -145.49K -3.64K
Interest Income - - - 10.91K -
Pretax Income -120.25K -10.83M -11.99M -1.63M -3.64K
Net Income -120.25K -10.79M -11.99M -1.63M -3.64K
Selling & General & Admin 4.51M 5.49M 5.04M 145.49K 3.64K
Research & Development 4.15M 5.38M 6.91M 2.56M -
Other Expenses - 34.96K -36.35K - -
Operating Expenses 8.66M 10.86M 11.95M 145.49K 3.64K
Interest Expense - - - - -
Selling & Marketing Expenses - - - 144.26K -
Cost & Expenses 8.66M 10.86M 11.95M 145.49K 3.64K
Income Tax - -34.96K -219.78K -3.80K -171.86K
Shares Outstanding (Basic) 228.00K 17.97K 9.40K 8.66K 8.66K
Shares Outstanding (Diluted) 228.64K 17.97K 9.40K 8.66K 8.66K
EPS (Basic) -0.53 -600.77 -1.28K -188.18 -0.42
EPS (Diluted) -0.53 -600.77 -1.28K -188.18 -0.42
EBITDA -95.21K -10.84M -11.93M -145.49K -3.64K
Depreciation & Amortization 25.05K 40.01K 69.17K 3.80M 171.86K